195 related articles for article (PubMed ID: 22398951)
1. Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait.
Bird JE; Smith PL; Wang X; Schumacher WA; Barbera F; Revelli JP; Seiffert D
Thromb Haemost; 2012 Jun; 107(6):1141-50. PubMed ID: 22398951
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
3. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
[TBL] [Abstract][Full Text] [Related]
4. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
Steen Burrell KA; Layzer J; Sullenger BA
J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
[TBL] [Abstract][Full Text] [Related]
5. Role of Factor XIa and Plasma Kallikrein in Arterial and Venous Thrombosis.
Visser M; Heitmeier S; Ten Cate H; Spronk HMH
Thromb Haemost; 2020 Jun; 120(6):883-993. PubMed ID: 32375196
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Pehrsson S; Johansson K; Kjaer M; Elg M
Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
[TBL] [Abstract][Full Text] [Related]
7. Defective thrombus formation in mice lacking endogenous factor VII activating protease (FSAP).
Subramaniam S; Thielmann I; Morowski M; Pragst I; Sandset PM; Nieswandt B; Etscheid M; Kanse SM
Thromb Haemost; 2015 Apr; 113(4):870-80. PubMed ID: 25427855
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
[TBL] [Abstract][Full Text] [Related]
9. Blocking of plasma kallikrein ameliorates stroke by reducing thromboinflammation.
Göb E; Reymann S; Langhauser F; Schuhmann MK; Kraft P; Thielmann I; Göbel K; Brede M; Homola G; Solymosi L; Stoll G; Geis C; Meuth SG; Nieswandt B; Kleinschnitz C
Ann Neurol; 2015 May; 77(5):784-803. PubMed ID: 25628066
[TBL] [Abstract][Full Text] [Related]
10. Titrating haemophilia B phenotypes using siRNA strategy: evidence that antithrombotic activity is separated from bleeding liability.
Metzger JM; Tadin-Strapps M; Thankappan A; Strapps WR; DiPietro M; Leander K; Zhang Z; Shin MK; Levorse J; Desai K; Xu Y; Lai K; Wu W; Chen Z; Cai TQ; Jochnowitz N; Bentley R; Hoos L; Zhou Y; Sepp-Lorenzino L; Seiffert D; Andre P
Thromb Haemost; 2015 Jun; 113(6):1300-11. PubMed ID: 25790442
[TBL] [Abstract][Full Text] [Related]
11. Improving the understanding of plasma kallikrein contribution to arterial thrombus formation using two plant protease inhibitors.
Salu BR; Pando SC; Brito MV; Medina AF; Odei-Addo F; Frost C; Naude R; Sampaio MU; Emsley J; Maffei FHA; Oliva MLV
Platelets; 2019; 30(3):305-313. PubMed ID: 29442535
[TBL] [Abstract][Full Text] [Related]
12. PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.
Kolte D; Bryant JW; Gibson GW; Wang J; Shariat-Madar Z
Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):154-66. PubMed ID: 22352684
[TBL] [Abstract][Full Text] [Related]
13. Plasma kallikrein: novel functions for an old protease.
Renné T; Gruber A
Thromb Haemost; 2012 Jun; 107(6):1012-3. PubMed ID: 22552331
[No Abstract] [Full Text] [Related]
14. Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.
Wang X; Smith PL; Hsu MY; Tamasi JA; Bird E; Schumacher WA
J Thromb Thrombolysis; 2007 Feb; 23(1):41-9. PubMed ID: 17111204
[TBL] [Abstract][Full Text] [Related]
15. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
Riano I; Prasongdee K
J Investig Med High Impact Case Rep; 2021; 9():23247096211012187. PubMed ID: 33940978
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic potential of the contact activation pathway.
Schmaier AH
Curr Opin Hematol; 2016 Sep; 23(5):445-52. PubMed ID: 27380557
[TBL] [Abstract][Full Text] [Related]
17. Arterial thrombosis is accelerated in mice deficient in histidine-rich glycoprotein.
Vu TT; Zhou J; Leslie BA; Stafford AR; Fredenburgh JC; Ni R; Qiao S; Vaezzadeh N; Jahnen-Dechent W; Monia BP; Gross PL; Weitz JI
Blood; 2015 Apr; 125(17):2712-9. PubMed ID: 25691157
[TBL] [Abstract][Full Text] [Related]
18. Role of plasma kallikrein in diabetes and metabolism.
Feener EP; Zhou Q; Fickweiler W
Thromb Haemost; 2013 Sep; 110(3):434-41. PubMed ID: 23676986
[TBL] [Abstract][Full Text] [Related]
19. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
20. A novel hirudin derivative inhibiting thrombin without bleeding for subcutaneous injection.
Zhao B; Zhang Y; Huang Y; Yu J; Li Y; Wang Q; Ma Y; Song HY; Yu M; Mo W
Thromb Haemost; 2017 Jan; 117(1):44-56. PubMed ID: 27904902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
